Print Friendly, PDF & Email

NCT/Study#

NCT03244384 /

A031501-JTCC

Phase III Randomized Adjuvant Study Of Pembrolizumab In Muscle Invasive And Locally Advanced Urothelial Carcinoma (AMBASSADOR) Versus Observation

DISEASE GROUP:
Genito-Urinary
current phase:
Phase III
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: